| STAAR SURGICAL CO. DL-,01 |
| USA |
| Gesundheit |
| US8523123052 / 870353 |
| SR3 (Frankfurt) / STAA (NASDAQ) |
| FRA:SR3, ETR:SR3, SR3:GR, NASDAQ:STAA |
| - |
| https://staar.com/ |
|
Staar Surgical Company designs, develops, manufactures, and sells implantable lenses for eye surgery, operating primarily in the ophthalmic medical devices sector. The company offers two main product categories: Implantable Collamer lenses (ICL) used..
>Volltext.. |
| 785.14 Mio. EUR |
| 659.25 Mio. EUR |
| 207.03 Mio. EUR |
| -34.66 Mio. EUR |
| -69.56 Mio. EUR |
| -1.41 EUR |
| 33.16 Mio. EUR |
| 132.42 Mio. EUR |
| -29.6 Mio. EUR |
| 2.74 |
| -32.77% |
| -250.89% |
| - |
| - |
| - |
| STAAR SURGICAL |
| 02.04.26 |
|